First Synthesis of Racemic Trans Propargylamino-Donepezil, a Pleiotrope Agent Able to Both Inhibit AChE and MAO-B, with Potential Interest against Alzheimer’s Disease
Open Access
- 27 December 2020
- Vol. 26 (1), 80
- https://doi.org/10.3390/molecules26010080
Abstract
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disease towards which pleiotropic approach using Multi-Target Directed Ligands is nowadays recognized as probably convenient. Among the numerous targets which are today validated against AD, acetylcholinesterase (ACh) and Monoamine Oxidase-B (MAO-B) appear as particularly convincing, especially if displayed by a sole agent such as ladostigil, currently in clinical trial in AD. Considering these results, we wanted to take benefit of the structural analogy lying in donepezil (DPZ) and rasagiline, two indane derivatives marketed as AChE and MAO-B inhibitors, respectively, and to propose the synthesis and the preliminary in vitro biological characterization of a structural compromise between these two compounds, we called propargylaminodonepezil (PADPZ). The synthesis of racemic trans PADPZ was achieved and its biological evaluation established its inhibitory activities towards both (h)AChE (IC50 = 0.4 µM) and (h)MAO-B (IC50 = 6.4 µM).Funding Information
- Région Normandie (RIN GreenChem)
- European Regional Development Fund (CERMN)
This publication has 24 references indexed in Scilit:
- Donecopride, a Swiss army knife with potential against Alzheimer's diseaseBritish Journal of Pharmacology, 2019
- Novel N-benzylpiperidine carboxamide derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2019
- Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of DonecoprideJournal of Medicinal Chemistry, 2015
- N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual InhibitorJournal of Medicinal Chemistry, 2014
- Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatmentProceedings of the National Academy of Sciences of the United States of America, 2014
- Multi-target-Directed Ligands To Combat Neurodegenerative DiseasesJournal of Medicinal Chemistry, 2008
- The Path from Anti Parkinson Drug Selegiline and Rasagiline to Multifunctional Neuroprotective Anti Alzheimer Drugs Ladostigil and M30Current Alzheimer Research, 2006
- The therapeutic potential of monoamine oxidase inhibitorsNature Reviews Neuroscience, 2006
- Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT4 receptor ligandsEuropean Journal of Medicinal Chemistry, 2000
- One-pot cyclization of alkoxy-3-aminoindan-1-ones.Tetrahedron Letters, 1991